Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopaminergic System and Mobility Resilience (RES)
NCT04325503Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Feb 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levodopa, sponsored by University of Michigan. Started Feb 2021; status: completed.
02
Drugs
levodopa
Beyond the preview
Go deeper on NCT04325503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325503.